CVI Holdings’s Xeris Biopharma Holdings XERS Stock Holding History

CVI Holdings’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-14,626	Closed	-$39K	–	120
2020 Q2	$39K	Buy	+14,626	New	+$50.9K	0.01%	62

Other funds holding XERS

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CVI Holdings's XERS Position: Q3 2020 in Review

CVI Holdings sold out of Xeris Biopharma Holdings (XERS) in Q3 2020, closing a stake of 14,626 shares — an estimated $39K sold.

CVI Holdings first reported a position in XERS in Q2 2020 and held it in 1 quarter. The position peaked at $39K in Q2 2020. 86 funds tracked by Wall St. Rank hold XERS as of Q3 2020.

CVI Holdings reported no remaining Xeris Biopharma Holdings position as of Q3 2020 after selling out during the quarter.
CVI Holdings sold 14,626 Xeris Biopharma Holdings shares in Q3 2020, an estimated $39K.
CVI Holdings first reported a position in Xeris Biopharma Holdings in Q2 2020 and held it in 1 quarter.
CVI Holdings's Xeris Biopharma Holdings position peaked at $39K in Q2 2020.
86 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2020.

Based on CVI Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.